SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-137599
Filing Date
2012-03-28
Accepted
2012-03-28 17:11:56
Documents
26
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d275067d10k.htm 10-K 1177716
2 WARRANT NO. 2012-1 IN FAVOR OF LEGEND SECURITIES, INC. d275067dex49.htm EX-4.9 91214
3 FIRST AMENDMENT TO CONTIGENT VALUE RIGHTS AGREEMENT d275067dex102.htm EX-10.2 27353
4 SECOND OMNIBUS AMENDMENT TO SECURITIES PURCHASE AGREEMENT d275067dex1037.htm EX-10.37 12793
5 LEASE BETWEEN GALENA BIOPHARMA, INC. AND LO 138, LLC d275067dex1043.htm EX-10.43 122911
6 LEASE AGREEMENT, EFFECTIVE AS OF APRIL 30, 2009 d275067dex1045.htm EX-10.45 111137
7 AMENDMENT NO. 1 TO LICENSE AGREEMENT, DATED JANUARY 13, 2012 d275067dex1046.htm EX-10.46 15280
8 SEPARATION AND TRANSITION AGREEMENT d275067dex1047.htm EX-10.47 33996
9 SUBSIDIARIES OF THE REGISTRANT d275067dex211.htm EX-21.1 3632
10 CONSENT OF BDO USA, LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d275067dex231.htm EX-23.1 1778
11 SARBANES-OXLEY ACT SECTION 302 CERTIFICATION OF MARK J. AHN d275067dex311.htm EX-31.1 9193
12 SARBANES-OXLEY ACT SECTION 302 CERTIFICATION OF CAITLIN KONTULIS d275067dex312.htm EX-31.2 9272
13 SARBANES-OXLEY ACT SECTION 906 CERTIFICATION OF MARK J. AHN AND CAITLIN KONTULIS d275067dex321.htm EX-32.1 3637
20 GRAPHIC g275067ex10_4346.jpg GRAPHIC 221702
21 GRAPHIC g275067ex10_4347.jpg GRAPHIC 257341
22 GRAPHIC g275067g17q90.jpg GRAPHIC 21139
23 GRAPHIC g275067g33o37.jpg GRAPHIC 22573
24 GRAPHIC g275067g35o58.jpg GRAPHIC 39421
25 GRAPHIC g275067g36l13.jpg GRAPHIC 10999
26 GRAPHIC g275067g72o39.jpg GRAPHIC 20318
  Complete submission text file 0001193125-12-137599.txt   5365049

Data Files

Seq Description Document Type Size
14 XBRL INSTANCE DOCUMENT rxii-20111231.xml EX-101.INS 541781
15 XBRL TAXONOMY EXTENSION SCHEMA rxii-20111231.xsd EX-101.SCH 28880
16 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxii-20111231_cal.xml EX-101.CAL 44102
17 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxii-20111231_def.xml EX-101.DEF 38039
18 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxii-20111231_lab.xml EX-101.LAB 217962
19 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxii-20111231_pre.xml EX-101.PRE 129180
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33958 | Film No.: 12721330
SIC: 2834 Pharmaceutical Preparations